A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis
- PMID: 2649023
- PMCID: PMC1003698
- DOI: 10.1136/ard.48.2.128
A tissue kallikrein in the synovial fluid of patients with rheumatoid arthritis
Abstract
Tissue kallikrein is an enzyme that forms the vasoactive peptide kallidin from an endogenous substrate L-kininogen. Tissue kallikrein has been identified in joint fluids and in inflammatory infiltrates within synovial membranes. It is suggested that tissue kallikrein and kinins have an important role in synovitis and joint damage. Immunoreactive tissue kallikrein and amidase activity were both measured in the synovial fluid of 24 patients with rheumatoid arthritis (RA) and 12 with osteoarthritis (OA). Active enzyme concentrations were higher in RA than in OA and correlated well with the lysosomal enzymes beta-glucuronidase and lactate dehydrogenase. Both total immunoreactive tissue kallikrein and the proenzyme values were similar in RA and OA. Tissue kallikrein was localised by immunocytochemistry to the polymorphonuclear leucocytes present in the synovial fluid and membranes of patients with RA.
Similar articles
-
Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.Inflamm Res. 1996 Apr;45(4):198-202. doi: 10.1007/BF02285161. Inflamm Res. 1996. PMID: 8741010
-
Kallikrein in synovial fluid with rheumatoid arthritis.Biochem Med Metab Biol. 1987 Apr;37(2):177-83. doi: 10.1016/0885-4505(87)90024-7. Biochem Med Metab Biol. 1987. PMID: 3036190
-
Identification and functional importance of plasma kallikrein in the synovial fluids of patients with rheumatoid, psoriatic, and osteoarthritis.Ann Rheum Dis. 1995 May;54(5):345-50. doi: 10.1136/ard.54.5.345. Ann Rheum Dis. 1995. PMID: 7794038 Free PMC article.
-
A synovial amidase acting on tissue kallikrein-selective substrate in clinical and experimental arthritis.Adv Exp Med Biol. 1986;198 Pt B:405-11. doi: 10.1007/978-1-4757-0154-8_52. Adv Exp Med Biol. 1986. PMID: 3643734
-
Presence of immunoreactive tissue kallikrein in human polymorphonuclear (PMN) leucocytes.Adv Exp Med Biol. 1989;247B:207-10. doi: 10.1007/978-1-4615-9546-5_34. Adv Exp Med Biol. 1989. PMID: 2692412
Cited by
-
Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies.Br J Pharmacol. 1991 Mar;102(3):774-7. doi: 10.1111/j.1476-5381.1991.tb12249.x. Br J Pharmacol. 1991. PMID: 1364852 Free PMC article.
-
Evidence for activation of the tissue kallikrein-kinin system in nociceptive transmission and inflammatory responses of mice using a specific enzyme inhibitor.Br J Pharmacol. 2000 Jul;130(5):1099-107. doi: 10.1038/sj.bjp.0703362. Br J Pharmacol. 2000. PMID: 10882395 Free PMC article.
-
Augmented plasma and tissue kallikrein like activity in synovial fluid of patients with inflammatory articular diseases.Inflamm Res. 1996 Apr;45(4):198-202. doi: 10.1007/BF02285161. Inflamm Res. 1996. PMID: 8741010
-
N-methyl pyrrolidone promotes ankle fracture healing by inhibiting inflammation via suppression of the mitogen-activated protein kinase signaling pathway.Exp Ther Med. 2018 Apr;15(4):3617-3622. doi: 10.3892/etm.2018.5842. Epub 2018 Feb 7. Exp Ther Med. 2018. PMID: 29545891 Free PMC article.
-
Kallikreins and kinins: mediators in inflammatory joint disease?Int J Exp Pathol. 1990 Aug;71(4):587-601. Int J Exp Pathol. 1990. PMID: 2205284 Free PMC article. Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical